FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

1636471000168109: Mercury Pharma MP 1:1 (THC 25:CBD 25) (cannabidiol 25 mg / 1 mL + delta-9-tetrahydrocannabinol 25 mg / 1 mL) oral liquid, 30 mL (trade product pack)


Status: current, Defined. Date: 30-Nov 2022. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4758391000168119 Mercury Pharma MP 1:1 (THC 25:CBD 25) (cannabidiol 25 mg / 1 mL + delta-9-tetrahydrocannabinol 25 mg / 1 mL) oral liquid, 30 mL (trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4758401000168117 Mercury Pharma MP 1:1 (THC 25:CBD 25) oral liquid, 30 mL en Synonym Active Case sensitive Australian Medicines Terminology module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mercury Pharma MP 1:1 (THC 25:CBD 25) oral liquid, 30 mL Is a delta-9-tetrahydrocannabinol 25 mg/mL + cannabidiol 25 mg/mL oral liquid, 30 mL true Inferred relationship Some
Mercury Pharma MP 1:1 (THC 25:CBD 25) oral liquid, 30 mL Is a trade product pack true Inferred relationship Some
Mercury Pharma MP 1:1 (THC 25:CBD 25) oral liquid, 30 mL has TP Mercury Pharma MP 1:1 (THC 25:CBD 25) true Inferred relationship Some
Mercury Pharma MP 1:1 (THC 25:CBD 25) oral liquid, 30 mL has TPUU Mercury Pharma MP 1:1 (THC 25:CBD 25) oral liquid true Inferred relationship Some 1847465607

Inbound Relationships Type Active Source Characteristic Refinability Group
Mercury Pharma MP 1:1 (THC 25:CBD 25) oral liquid, 30 mL, dropper container Is a True Mercury Pharma MP 1:1 (THC 25:CBD 25) oral liquid, 30 mL Inferred relationship Some

Reference Sets

Trade product pack reference set

Back to Start